The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ANIKA THERAPEUTICS INC COM 035255108 6,670 115,000 SH   SOLE   115,000 0 0
ANTHEM INC COM 036752103 10,481 55,200 SH   SOLE   55,200 0 0
BIOGEN INC COM 09062X103 6,388 20,400 SH   SOLE   20,400 0 0
CHARLES RIV LABS INTL INC COM 159864107 6,569 60,812 SH   SOLE   60,812 0 0
CIGNA CORPORATION COM 125509109 6,580 35,200 SH   SOLE   35,200 0 0
GILEAD SCIENCES INC COM 375558103 6,206 76,600 SH   SOLE   76,600 0 0
LABORATORY CORP AMER HLDGS COM NEW 50540R409 6,386 42,300 SH   SOLE   42,300 0 0
LIGAND PHARMACEUTICALS INC COM NEW 53220K504 6,522 47,900 SH   SOLE   47,900 0 0
MCKESSON CORP COM 58155Q103 10,538 68,600 SH   SOLE   68,600 0 0
MEDTRONIC PLC SHS G5960L103 6,385 82,100 SH   SOLE   82,100 0 0
PFIZER INC COM 717081103 6,472 181,300 SH   SOLE   181,300 0 0
WATERS CORP COM 941848103 6,445 35,900 SH   SOLE   35,900 0 0